Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
NCT07668323Phase 3Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tissue-plasminogen activator and tenecteplase in ischemic stroke (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Proportion of patients with favorable functional outcome (mRS 0-2) at 90 days, Symptomatic intracranial hemorrhage at 48 hours and 1 more. Started Sep 2026; status: recruiting.
02
Drugs
tissue-plasminogen activatortenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07668323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668323.